'A Phase II Open-Label, Non-Randomized, Single-Center Trial to Determine the Optimal Myocardial Perfusion Image Acquisition Time Following BMS068645 Administration
Latest Information Update: 03 Jun 2014
At a glance
- Drugs Apadenoson (Primary) ; Tc 99m sestamibi
- Indications Cardiovascular disorders
- Focus Diagnostic use
- Sponsors Forest Laboratories
Most Recent Events
- 03 Jun 2014 New trial record